Figures
Abstract
Eukaryotic life has been shaped fundamentally by the integration of bacterial endosymbionts. The trypanosomatid Angomonas deanei that contains a β-proteobacterial endosymbiont, represents an emerging model to elucidate initial steps in symbiont integration. Although the repertoire of genetic tools for A. deanei is growing, no conditional gene expression system is available yet, which would be key for the functional characterization of essential or expression of toxic proteins. Development of a conditional expression system based on endogenous RNA polymerase II (POLII) is hampered by the absence of information on transcription signals in A. deanei as well as the unusual genetic system used in the Trypanosomatidae that relies on read-through transcription. This mode of transcription can result in polar effects when manipulating expression of genes in their endogenous loci. Finally, only a few resistance markers are available for A. deanei yet, restricting the number of genetic modifications that can be introduced into one strain. To increase the range of possible genetic manipulations in A. deanei, and in particular, build the base for a conditional expression system that does not interfere with the endogenous gene expression machinery, here we (i) implemented two new drug resistance markers, (ii) identified the spacer upstream of the rDNA array on chromosome 13 as transcriptionally silent genomic locus, and (iii) used this locus for engineering an ectopic expression system that depends on the T7 RNA polymerase expressed from the δ-amastin locus. We show that transgene expression in this system is independent of the activity of endogenous RNA polymerases, reaches expression levels similar to the previously described POLII-dependent expression from the γ-amastin locus, and can be applied for studying endosymbiosis. In sum, the new tools expand the possibilities for genetic manipulations of A. deanei and provide a solid base for the development of an ectopic conditional expression system.
Citation: Kröninger L, Maurya AK, Stiebeling C, Stirba FP, Kim Z, Nowack ECM (2025) T7 RNA polymerase-based gene expression from a transcriptionally silent rDNA spacer in the endosymbiont-harboring trypanosomatid Angomonas deanei. PLoS One 20(5): e0322611. https://doi.org/10.1371/journal.pone.0322611
Editor: Claude Prigent, Centre de Recherche en Biologie cellulaire de Montpellier, FRANCE
Received: January 30, 2025; Accepted: March 25, 2025; Published: May 30, 2025
Copyright: © 2025 Kröninger et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The datasets generated and/or analyzed in the course of this study are included in this published article and its supplementary information files. Further data, including raw data and quantitative analyses, can be found in the Data Hub https://archive.nfdi4plants.org/records/3febm-0sd52. The data is linked to the following DOI: https://doi.org/10.60534/3febm-0sd52.
Funding: This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation; www.dfg.de) – SFB1535, Project ID 458090666 (to E.C.M.N.) and a PhD fellowship of the Jürgen Manchot (www.manchot.org) Graduate School ‘‘Molecules of Infection’’, MOI IV (to A.K.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
The trypanosomatid Angomonas deanei is an emerging model system for endosymbiosis [1,2]. It harbors a β-proteobacterial endosymbiont of the Alcaligenaceae, which co-evolved with its host for 40–120 million years [3]. The endosymbiont supplies its host with essential metabolites and co-factors, underwent pronounced genome reduction [4], and divides strictly synchronously with its host cell [5], indicating an advanced level of endosymbiont integration. However, information on the exact molecular mechanisms of host-symbiont communication and control is scarce.
A few genetic tools have been developed for the asexual diploid A. deanei. Protocols available allow to efficiently generate heterozygous and homozygous knock-out mutants by one or two rounds of homologous recombination, respectively [6,7], or by CRISPR/Cas-based technology [8]. Furthermore, two amastin loci that have been called the δ-amastin and γ-amastin locus, coding for highly expressed surface glycoproteins (GenBank accessions CAD2222965.1 and CAD2215701.1, respectively) that are dispensable for the organism under standard growth conditions in the laboratory, were successfully hijacked for high level transgene expression [6]. Expression of fluorescent fusion proteins from these loci has been instrumental for the identification of a number of endosymbiont-targeted host proteins (short ETPs) that are assumed to be involved in host/symbiont interaction [6,7]. However, inducible gene expression systems that would be important for the expression of toxic gene products and the development of conditional gene knock-outs of essential genes are not available yet, and although a protocol for RNA interference-based gene knock-downs has been published [9], it appears to be difficult to reproduce in our hands. Recently, morpholino antisense oligos (MAOs) have been successfully employed in A. deanei to knock-down ETP9 and characterize it as a nucleus-encoded dynamin-like protein essential for endosymbiont division [10]. However, MAO production is relatively expensive and their applicability depends on the availability of suitable binding sites in the 5’ untranslated region (5’ UTR) of the target gene. These limitations call for the development of further genetic tools.
Trypanosomatids use an uncommon gene expression system. They produce long polycistronic mRNA strands from unidirectional gene clusters containing dozens of genes [11–14]. During mRNA maturation, polycistronic mRNAs are processed by coupled trans-splicing and polyadenylation reactions resulting in mature monocistronic mRNAs that carry at their 5’ ends a common spliced leader (a capped 39-nt RNA molecule) [13,15]. Regulation of gene expression occurs on the mRNA level by stabilizing elements in the 5’ and 3’ UTRs directly influencing gene expression [13]. Consequently, transgenes that are inserted into any expressed genomic locus are transcribed by read-through, but their expression cannot be conditionally modulated or interrupted, e.g., using operator/repressor pairs, without affecting expression of downstream genes. This makes the development of inducible gene expression systems challenging.
Due to their medical relevance, other trypanosomatids such as Trypanosoma spp. and Leishmania spp. that do not carry an endosymbiont, are far better studied and advanced genetic tools are available for them [16–20]. These tools include conditional gene expression systems, that make use of transcriptional regulators, such as the tetracycline-inducible repressor (TetR) [21] or the cumate repressor (CymR) [22]. A common strategy to prevent interference with the endogenous gene expression machinery in these systems, is ectopic expression from transcriptionally silent genomic loci. Such silent loci have been found, for example, in transcriptionally inactive mini-chromosomes in Trypanosoma brucei [23] (which do not exist in A. deanei) or upstream of the promoter for the 18S rRNA gene (hereafter referred to as the rDNA spacer) [24,25]. In the latter insertion site, the inducible gene is inserted oriented in the opposite direction to that of the 18S rDNA [26].
In T. brucei, some promoter sequences such as the procyclic acidic repetitive protein (PARP) promoter have been described and used to establish conditional expression systems based on the endogenous POLII [24,26]. In A. deanei, however, virtually nothing is known about transcription initiation. Other expression systems in trypanosomatids make use of the exogenous bacteriophage T7 RNA polymerase (T7RNAP) [21,27–31]. Advantages of the T7RNAP are not only that it is a single subunit enzyme that can be produced heterologously in a wide variety of organisms but also that promoter and terminator sequences are well-characterized and comparably short [32]. Moreover, the enzyme shows an extraordinarily high activity, beyond the activity of endogenous RNA polymerases, in some bacteria such as Escherichia coli [33]. In T. brucei, T7RNAP-dependent gene expression exceeded POLII-dependent expression with a PARP promoter by 5-fold [27].
To increase the experimental versatility of A. deanei as an endosymbiosis model, here we describe a transcriptionally silent locus in its nuclear genome. We demonstrate that this locus can be used for T7RNAP-driven expression of transgenes. We compare the expression level of this newly introduced system to the previously described expression system from the amastin loci and implement blasticidin and nourseothricin resistance genes as new selectable markers in A. deanei. Together the new protocols contribute to the growing genetic toolbox that supports the establishment of A. deanei as a versatile endosymbiosis model.
Results
Identification of potentially silent genetic loci as integration site for transgenes in A. deanei
To identify potentially silent genomic loci in A. deanei that could be used for transgene expression by an exogenous transcription machinery, we searched the A. deanei nuclear genome for ribosomal repeats and found seven copies on different chromosomes (Fig 1). Putative protein-coding sequences upstream of the ribosomal arrays were identified using the auto-annotation tool of Benchling (https://www.benchling.com) and comparisons to the curated annotations in the TriTryp Database (https://tritrypdb.org) [34]. The first coding sequence upstream of the ribosomal arrays was found 3.2 kbp away from the 18S rDNA (on chromosome 25) suggesting that these intergenic spacers are indeed non-coding. All seven rDNA spacers show high sequence similarity in the first 1.5–2 kbp upstream of the ribosomal arrays, but then diverge with increasing distance from the ribosomal arrays (see alignment of the first 4000 bp upstream of the ribosomal array in S1 Appendix).
The highly conserved ribosomal repeats were found on seven different chromosomes (chrom.) and are marked in orange. Putative protein-coding sequences upstream of the ribosomal repeats are shown in blue. Open reading frames marked in grey did not show homologs in other trypanosomatids (using BLASTp against the NCBI non-redundant database) and are unlikely to represent true protein-coding genes. The targeted insertion site on chromosome 13 is marked in red and transgene orientation is indicated by the broken red arrow.
Heterologous expression of the T7RNAP in A. deanei
To implement an RNA polymerase in A. deanei that works independently of the endogenous expression machinery, we inserted the T7RNAP-coding sequence into the δ-amastin locus. For selection, the T7RNAP-coding sequence was linked upstream via the intergenic region between GAPDH-I and II genes (GAPDH-IR, that contains signals for mRNA maturation and stabilization [6]) to the neomycin phosphotransferase gene (neoR) (Fig 2A). Transfectants were selected on neomycin and the clonal strain obtained (Adea319) was verified by PCR with primers binding outside of the integration site (Fig 2B). Production of the T7RNAP was verified by Western blot analysis (Fig 2C).
(A) Genomic map of Adea319 and the A. deanei wildtype (WT) in the δ-amastin (δ-ama) locus. Primers 49 + 545, that were used for the verification of the insertion of the T7RNAP gene-containing construct, are marked in orange. (B) Verification of the integration of the T7RNAP expression cassette in Adea319 by PCR. The WT served as a control and showed only the δ-amastin WT locus (3.3 kbp, grey arrowhead) plus a weak unspecific band at 6.0 kbp. The recombinant locus in Adea319 additionally yielded the predicted product at 6.6 kbp (black arrowhead). (C) Verification of production of the ~ 100 kDa T7RNAP (black arrowhead) by Western blot using an α-T7RNAP primary antibody (right picture). Trichloroethanol (TCE) staining of the SDS-polyacrylamid gel electrophoresis (PAGE) before blotting confirmed equal loading of the WT and Adea319 raw extract samples (left picture).
Implementation of new antibiotic resistance markers for A. deanei
So far, only a limited set of antibiotic resistance markers has been established for A. deanei strain ATCC PRA-265 [6,7], namely neoR, the hygromycin phosphotransferase (hygR), and the phleomycin-binding protein (phleoR). To increase the number of resistance markers, we tested blasticidin and nourseothricin and their resistance genes, blasticidin deaminase (blastR) and nourseothricin acetyltransferase (noursR), respectively, as potential selection markers in A. deanei. To this end, we generated two strains, Adea373 and Adea384, expressing blastR (alone) and noursR (in combination with neoR) from the δ-amastin locus and compared their growth with the WT on various concentrations of the respective antibiotics. Whereas growth of the WT was heavily affected at blasticidin concentrations ≥75 µg/ml and nourseothricin concentrations ≥200 µg/ml, Adea373 and Adea384 were resistant to the respective antibiotics, and grew up to concentrations of 200 µg/ml blasticidin or 400 µg/ml nourseothricin, respectively, without noticeable growth defects (Fig 3). Subsequently, 75 µg/ml blasticidin or 200 µg/ml nourseothricin were used for mutant selection.
(A) Genomic map of Adea373 and growth of A. deanei WT and Adea373 on increasing blasticidin concentrations over 4 days. (B) Genomic map of Adea384 and growth of A. deanei WT and Adea384 on increasing nourseothricin concentrations over 4 days. Blasticidin (A) and nourseothricin (B) concentrations are color coded as indicated in the graphs. The graphs display mean values and standard deviations from 3 biological replicates.
T7RNAP-driven expression from the rDNA spacer
Next, we aimed for the insertion of a transgene with T7 transcription signals into the rDNA spacer on chromosome 13 (chr13 rDNA spacer, see Fig 1) to test functionality of the T7RNAP. As selection marker and reporter cassette we made use of blastR flanked by sections of intergenic regions that trigger trans-splicing and polyadenylation during mRNA maturation, namely a 252 nt-long fragment of the intergenic region upstream of the δ-amastin gene (“spliced leader donor”, SLD) as 5’ flank and the complete GAPDH-IR as 3’ flank (Fig 4A). The T7 promoter and the T7 terminator were added at the 5’ and 3’ ends of this cassette, respectively. Finally, 600 bp-long sequences flanking the genomic target locus (see S1 Appendix) were added upstream and downstream of the T7 transcription signals for homologous recombination. Next, the T7RNAP-producing strain, Adea319, was transfected with this blastR integration cassette and blasticidin was added to the transfectants 6 h post-transfection.
(A) Genomic map of the chr13 rDNA spacer of Adea400. Primer pairs 2211 + 2748 and 2753 + 2210 that were used for the verification of the insertion of the blastR-containing construct and expected products are shown in orange and blue-green. The annealing site of the Southern blot probe is marked with an icon in magenta. (B, C) Verification of integration of the blastR-containing construct into the targeted rDNA spacer by PCR (B, orange primer pair 2211 + 2748 and C, blue-green primer pair 2753 + 2210). The WT served as a control and showed no (B) or a faint unspecific product (C), whereas samples of two individual clones (C1 and C2) yielded the expected product at ~ 800 bp (B) and ~ 700 bp (C). (D) Verification of insertion into the chr13 rDNA spacer in Adea400 by Southern blot. The blastR-targeting probe yielded only a single band of the expected size at 4746 bp for Adea400 but not for the WT control (see S1 Table for expected sizes and S1 Fig for an additional Southern blot on BamHI-digested DNA). (E) Growth of A. deanei WT, Adea319, and Adea400 on neomycin (neo) and neomycin/blasticidin (neo/blast) over 4 days. (F) Knock-out strategy and genomic map of Adea442 depicting the interruption of the T7RNAP-encoding gene by a hygR-containing cassette and partial removal of the gene with only N- and C-terminal domains (nT7/cT7) remaining. (G) Verification of the successful T7RNAP knock-out by PCR using primers 2045 + 2966 (labelled in orange in the genomic map). Adea319 with functional T7RNAP gene (black arrowhead), Adea442 with successfully disrupted T7RNAP gene (grey arrowhead). (H) Growth of A. deanei WT, Adea373, and the T7RNAP knock-out strain Adea442 on hygromycin (hyg), blasticidin (blast), and hygromycin/blasticidin (hyg/blast) over 4 days. In (E) and (H) mean values and standard deviations from 3 biological replicates are displayed.
Recombinant clones recovered after 5–7 days suggesting that blastR is expressed in sufficient amounts to render the cell resistant. As mentioned above, the rDNA spacers on different chromosomes are highly similar, so that i) insertion into a non-targeted locus and ii) multiple insertions into several rDNA spacers could not be excluded. To explore these issues, first we verified the insertion of the blastR-containing construct into an rDNA spacer by PCR (Fig 4B, 4C). Then, we identified BclI and SpeI as restriction enzymes that allow to distinguish between insertions into the rDNA spacers on different chromosomes by Southern blot analysis due to restriction length polymorphisms (see S1 Table). Southern blot analysis of Adea400 with BclI and SpeI yielded a single band of 4746 bp, indicative of an insertion specifically into the chr13 rDNA spacer (Fig 4D). Lastly, growth experiments (Fig 4E) revealed that the doubling time of Adea400 on blasticidin/neomycin (6.9 ± 0.2 h) and the T7RNAP-producing strain Adea319 on neomycin alone (6.9 ± 0.2 h) were identical. And both strains grew only slightly slower than the WT without antibiotics (doubling time of 6.6 ± 0.1 h).
To exclude that the endogenous transcription machinery of A. deanei is responsible for blastR expression from the rDNA spacer, we generated a strain derived from Adea400 (named Adea442), in which the T7RNAP-encoding gene was interrupted by a hygR cassette as well as partially removed (Fig 4F). We first verified the successful insertion into the target locus by PCR (Fig 4G) and then tested the verified strain for blasticidin resistance. On hygromycin alone, Adea442 showed similar growth rates (doubling time 6.6 ± 0.4 h) as A. deanei WT without antibiotics (doubling time 6.1 ± 0.3 h) and the blasticidin resistant strain Adea373 on blasticidin (doubling time 6.4 ± 0.1 h) (Fig 4H). However, no growth of Adea442 was observed on blasticidin. This result clearly demonstrates that blastR expression from the chr13 rDNA spacer is controlled by the T7RNAP system and not the endogenous transcription machinery.
Analysis of gene expression levels
To compare the expression level between the T7RNAP-dependent system and POLII-dependent expression from the amastin loci, we generated a strain that expresses the red fluorescent protein mScarlet fused to ETP1 (Adea456) from the chr13 rDNA spacer. ETP1 is one of the host-encoded ETPs and localizes to the endosymbiont periphery [7]. The coding sequence for the fusion protein was part of an integration cassette containing blastR as selection marker (Fig 5A).
(A) Genomic map of the chr13 rDNA spacer of Adea456 containing the gene encoding mScarlet-ETP1. The annealing site of the Southern blot probe is marked with an icon in magenta. (B) Verification of insertion in the chr13 rDNA spacer in Adea456 by Southern blot with BclI and SpeI. The WT and blasticidin resistant strain Adea400 served as controls. The blastR-targeting probe yielded single bands of the expected sizes for Adea400 (4746 bp) and Adea456 (4345 bp) but not for the WT (see S1 Table for expected sizes). (C) Growth of A. deanei WT without antibiotics and Adea456 on neomycin/blasticidin over 4 days. (D) Epifluorescence microscopic analysis of Adea126 and Adea456 expressing mScarlet-ETP1. Cell shape is indicated by white dashed lines. DIC, differential interference contrast; H, blue channel (visualizing Hoechst 33342); mSc, red channel (visualizing mScarlet). Scale bar represents 5 µm. (E) Quantification of fluorescent and non-fluorescent cells of the WT, Adea126, and Adea456 based on epifluorescence microscopy pictures. For each cell line at least 250 cells were analyzed. (F) In-gel fluorescence assay detecting red fluorescence in raw extracts of the WT, Adea126, and Adea456. TCE, TCE-stained total protein; In-gel fluor., in-gel fluorescence; M, marker. Note that the assay conditions result in incomplete protein denaturation resulting in several bands for mScarlet-ETP1 (69 kDa).
First, targeted insertion of the integration cassette into the chr13 rDNA spacer in Adea456 was verified by Southern blot (Fig 5B and S1 Fig). While the DNA load seemed to be slightly lower in Adea400 compared to Adea456 (see gel picture), the Southern blot signal was more pronounced in Adea400. Hence, it is possible that the integration cassette inserted twice (in both alleles) in Adea400 but only once in Adea456. Growth of Adea456 (doubling time of 6.6 ± 0.1 h) was only slightly slower than in the WT (6.3 ± 0.1 h) (Fig 5C). Next, the expression level of mScarlet-ETP1 was analyzed by an in-gel fluorescence assay and homogeneity of expression by epifluorescence microscopy. The WT and Adea126, which produces mScarlet-ETP1 from the γ-amastin locus [7], served as references. Microscopically, Adea456 and Adea126 showed comparable mScarlet fluorescence patterns (Fig 5D and S2 Fig) with the endosymbiont being labelled in its periphery in 98 and 100% of the cells, respectively (Fig 5E). Using the same microscope settings, in only ~1% of the WT cells a weak autofluorescent signal was recorded. The in-gel mScarlet fluorescence intensity (normalized to TCE-stained total protein) for Adea456 was approximately 20% weaker than for Adea126 but still in a similar range (Fig 5F).
Discussion
Bacterial endosymbionts are widespread across eukaryotes and profoundly impact physiology and evolution of their hosts [35–37]. Although the genomes of countless bacterial endosymbionts have been sequenced and hence, metabolic complementation between host and endosymbiont are quite well understood in many systems, our understanding of the molecular mechanisms that enable metabolic complementation, signaling, and exertion of control between the symbiotic partners lacks far behind. A central problem for dissecting these questions is that endosymbiotic systems that readily grow in the laboratory and can be efficiently genetically modified are scarce. With the current work we contribute to further develop A. deanei into such a much sought after, versatile model for the dissection of host-endosymbiont interactions. To this end, we implemented new resistance markers, identified a transcriptionally silent genomic locus, and, most importantly, used this locus to develop an ectopic gene expression system that is independent of the endogenous transcription machinery.
As new selectable markers we introduced noursR and blastR and determined by titration 75 µg/ml blasticidin or 200 µg/ml nourseothricin as selective concentrations that efficiently kill the WT cells whereas resistance cassette-carrying transformants are unaffected (Fig 3). These selection markers are commonly used in other trypanosomatids but effective selective concentrations vary between strains. E.g. inhibitory concentrations of 0.7–10 µg/ml blasticidin [38,39] and 2–50 µg/ml nourseothricin [38,40] are reported for Leishmania sp.; and 2–10 µg/ml blasticidin [39,41] and 500 µg/ml nourseothricin [42] for Trypanosoma sp.. Together with the previously implemented neoR, hygR, and phleoR, these additional selectable markers allow to introduce up to five selectable cassettes into the same A. deanei strain now.
As an insertion site for ectopic gene expression, we chose the chr13 rDNA spacer into which expression cassettes were inserted in reverse orientation with respect to the rDNA array. Inactivity of endogenous RNA polymerases in this locus was evident by the sensitivity of strain Adea442, that carries a blastR T7 expression cassette in the chr13 rDNA spacer but no functional T7RNAP gene, to selective concentrations of blasticidin (Fig 4H). Although the exact RNA polymerase I promoter that is needed for the production of rRNAs from the rDNA arrays, is not known in A. deanei, studies from T. brucei suggest that the promoter and the transcriptional start are ~ 1.2 kbp upstream of the 18S rDNA [25,43,44]. If the promoter is in the same position in A. deanei, it would be within the 5’ flank that was used for homologous recombination, resulting in insertion of the cassette upstream of this putative promoter region (see S1 Appendix). Hence, it is unlikely that integration of expression cassettes into this site interferes with transcription of the rDNA array downstream and our growth analyses demonstrate that even in strain Adea400, in which insertion of the expression cassette apparently occurred in both copies of chr13, growth is not impaired compared to its parental strain Adea319 which expresses only T7RNAP but carries no additional expression cassettes in the chr13 rDNA spacer (Fig 4E). Although the 5’ flank that we used for homologous recombination showed a high degree of sequence similarities between the rDNA spacers of the seven different chromosomes (see Fig 1 and S1 Appendix), in all clones that we obtained from transfections with insertion cassettes that carry 600 bp flanks amplified from the chr13 rDNA spacer, homologous recombination occurred into the chr13 rDNA spacer. Hence, the 3’ flank that shows more sequence divergence between different chromosomes, apparently was sufficient to guide insertion of the cassette specifically into the targeted integration site.
As an exogenous RNA polymerase for the ectopic gene expression system, we relied on the T7RNAP expressed from the δ-amastin locus. Although the δ-amastin locus is up to this point the strongest expression locus for transgenes known in A. deanei and ranges on rank 35 of the most highly expressed genes in A. deanei [6], T7RNAP expression did not result in pronounced toxicity as evidenced by the only very mild growth reduction of T7RNAP-expressing cell lines compared to WT (Fig 4E). In E. coli, high T7RNAP levels can be toxic [45] and similar effects were observed in T. brucei. In the latter, initial attempts to generate transgenic lines that express the T7RNAP from the highly expressed PARP locus, were repeatedly unsuccessful [46]. This obstacle was solved by placing the T7RNAP-encoding gene into the weaker β-tubulin expression locus [24], suggesting that high T7RNAP concentrations are lethal.
At the same time, the T7RNAP levels obtained by expression from the δ-amastin locus resulted in high levels of T7RNAP-driven expression of transgenes that are flanked by T7 transcription signals. T7RNAP-dependant expression of blastR (strain Adea400) rendered cells resistant to the same selective blasticidin concentration as cells with POLII-dependent expression of blastR from the δ-amastin locus (strain Adea373) (compare Figs 3A and 4E). Furthermore, T7RNAP-dependent expression of mScarlet-ETP1 (strain Adea456), resulted in protein levels that were well detectable by epifluorescence microscopy (Fig 5D) and only 20% lower than those that were obtained when expressing the same fusion protein POLII-dependently from the γ-amastin locus (strain Adea126) (Fig 5F). These results highlight the new expression system as a suitable tool for investigating symbiosis-related proteins such as the ETPs.
Finally, the new ectopic expression system and resistance markers now provide the basis for the development of advanced gene expression systems, in which the ectopic expression of a gene of interest can be modulated by transcriptional regulators, such as TetR (in its ON or OFF variant [26,47,48]) or CymR [49] without triggering polar effects caused by interference with the endogenous gene expression machinery. Conditional expression would allow to study the effect of the expression of toxic proteins. Furthermore, conditional ectopic expression of a copy of a gene of interest in its null mutant background would enable conditional gene knock-out strategies that would leverage the dissection of cellular functions of essential gene products. Expression strength of this system can be modulated, if needed, by (i) taking advantage of known T7 promoter variants with decreased [50,51] or increased activity [52], (ii) increasing the copy number of the transgene integrated into the same or different rDNA spacers or (iii) by integrating the T7 expression cassettes into episomal elements (e.g., plasmids) which is routinely used, for example, in L. tarentolae [53] and T. brucei [46].
Materials and methods
Generation of transgenic cell lines
A. deanei (ATCC PRA-265) was grown in brain heart infusion (BHI, Sigma Aldrich) medium supplemented with 10 μg/ml of hemin (Sigma-Aldrich) at 28 °C as described before [6]. Recombinant strains were generated by transfection with specific integration cassettes that had been excised from their storage vectors prior to transfection (see S2 Table and S3 Table). For the excision of the integration cassettes EcoRI or EcoRV/EcoRI (both New England Biolabs) were used. Transfections were performed as described before [7]. After transfection and recovery, cells were mixed with specific antibiotics for selection [neomycin/G418 (Sigma-Aldrich) at 500 µg/ml, hygromycin B (Invivogen) at 500 µg/ml, blasticidin S (Invivogen) at 75 µg/ml, and nourseothricin (Carl Roth) at 200 µg/ml] before dilution and distribution over a 96-well plate [7]. Cells typically recovered after 5–9 days, and correct insertion of the transgenes was verified by PCR and/or Southern blot analysis. A list of all strains used in this study is given in S3 Table.
Growth analyses
For the analysis of the growth behavior of different A. deanei strains, precultures were grown to mid-exponential phase (approximately 1–5 x 107 cells/ml) with all selective drugs that would allow growth of the specific strains. Then, three replicates were prepared with 5 ml BHI plus hemin and antibiotics as indicated and inoculated to an initial cell density of 1 x 105 cells/ml. The tubes were incubated at 28 °C without agitation and the cell density was measured every 20–24 h using the MultiSizer 4e (Beckman Coulter).
Analysis of homologous recombination by Southern blot
Southern blot was performed as described previously [7]. Each DNA sample contained 7 µg of purified DNA. The DNA was digested using restriction enzymes BclI and SpeI or only BamHI (New England Biolabs). A 393 bp DIG-labelled probe against blastR was generated by PCR using primers 3174 and 3175 (see S3 Table) and the DIG DNA Labelling Mixture (Roche) according to the manufacturer’s instructions. Hybridization was conducted at a temperature of 48 °C.
Construction of plasmids
All plasmids for this study were products of Gibson [54] or Golden Gate [55] assemblies as described previously [7]. The cloning fragments, which were needed for the assemblies, were generated by PCR using the Phusion polymerase (New England Biolabs) and the primers and templates are listed in S2 Table. The correct sizes of cloning fragments were verified by electrophoresis. PCR products matching the expected sizes were excised from the gel and purified using the Monarch DNA Gel Extraction kit (New England Biolabs). The concentration of the DNA was determined using the NanoPhotometer NP80 (Implen). The molar concentration of the insert(s) usually exceeded the vector backbone concentration by a factor of 3. After the assembly, 1 µl of DpnI was added to each assembly mix to remove residual PCR template present in the mix. Then, E. coli TOP10 cells were transformed with the assembly mix and recombinant cells selected on lysogeny broth (LB) plates containing 100 µg/ml ampicillin. Recovered clones were inoculated in 5 ml LB liquid medium with ampicillin (see above) and used for plasmid purification (Monarch Plasmid Miniprep kit, New England Biolabs). Plasmids were verified by control digests and sequencing (Microsynth).
Epifluorescence microscopy
Microscopy slides were prepared from mid-exponential cultures (approximately 1–5 x 107 cells/ml) as described before [7]. Images were taken with the Axio Imager A.2 equipped with the AxioCam MRm and an Illuminator HXP 120 V (all instruments from Zeiss) and processed with Zen Blue v2.5 (Zeiss) as described previously [7]. A. deanei WT cells served as negative control and its autofluorescence was used to define a suitable fluorescence threshold. For post-processing of the pictures Fiji [56] was used.
Western blot
For the detection of specific proteins, we grew 10 ml cultures of the relevant strains to mid-exponential phase, harvested the cells by centrifugation, and precipitated the proteins using trichloroacetic acid [7]. The precipitate was resuspended in urea buffer (8 M urea, 100 mM Tris, 5.25 mM EDTA, pH 8.6) and the protein concentration was determined using Pierce 660nm Protein Assay Reagent (Thermo Fisher Scientific). For each sample, 25 µg protein were mixed with Lämmli sample buffer (final concentrations: 63 mM Tris-HCl, pH 6.8, 10 mM dithiothreitol, 10% glycerol v/v, 2% SDS w/v, and 0.0025% w/v bromophenol blue), incubated for 5 min at 95 °C, and loaded onto a 10% SDS polyacrylamid gel containing 0.5% TCE. PAGE and protein blot to a PVDF membrane (Amersham Hybond, 0.45 nm, Thermo Fisher Scientific) were performed as described previously [7]. After blotting, proteins were detected immunologically. In brief, the membrane was blocked with 5% w/v milk powder for 1 h at room temperature and washed with 1x PBST (phosphate-buffered saline including 0.05% v/v Tween-20). For the detection of the T7RNAP, α-T7RNAP antibody (29943-1-AP, Proteintech, 1:5000 dilution) was used overnight at 4 °C and α-rabbit IgG HRP conjugate (7074, CellSignaling, 1:10,000 dilution) for 1 h at room temperature. Chemiluminescence was started by addition of SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific) and recorded using the ChemiDoc MP (Biorad).
In-gel fluorescence assay
For the detection of in-gel fluorescence of mScarlet, samples were prepared as described by Sanial et al. [57] with minor modifications. First, 15 ml cultures of the relevant strains were grown to mid-exponential phase, cells were harvested by centrifugation, washed twice using 1x PBS, and resuspended in 1 ml 1x PBS. Before cell lysis, cOmplete EDTA-free protease inhibitor tabs (Roche) and a few grains of DNase (Carl Roth) were added and the cells were lysed by sonication using the UP100H (Hielscher) with 5 x 18 pulses (cycle 0.8, amplitude ~60%, MS1 sonotrode). Cell debris and intact cells were removed by centrifugation (3000 rpm, 4 °C, 5 min) and the protein concentration of the supernatant was determined using the Pierce 660nm Protein Assay Reagent (ThermoFisher) and the FLUOstar Omega Plate Reader (BMG Labtech). 25 µg of protein were mixed with Lämmli sample buffer (final concentrations: 50 mM Tris-HCl, pH 6.8, 10% glycerol v/v, 2% SDS w/v, 2.5 mM EDTA, and 0.005% w/v bromophenol blue, plus 12.5 mM dithiothreitol), heated to 50 °C for 5 min and applied to a 12.5% SDS polyacrylamid gel containing 0.5% v/v TCE. The electrophoresis ran at 40 mA until the marker bands (Prestained Ladder, Thermo Fisher Scientific) were fully resolved. Finally, mScarlet fluorescence was recorded with the ChemiDoc MP (Biorad) using the UV tray and the “Cy3” filter. Afterwards, loading of the gel was visualized using TCE fluorescence with the UV tray and the “Stain-free gel” setting of the ChemiDoc MP (Biorad). The intensities of the mScarlet and TCE bands were estimated with Fiji [56] and normalized by the TCE signals.
Supporting information
S1 Appendix. Alignment of the 4,000 nucleotides upstream of the start of the 18S rRNA genes on different chromosomes in A. deanei.
Regions flanking the insertion site that were used for homologous recombination are highlighted in yellow (3’ flank) and red (5’ flank). rDNA sequences in A. deanei were identified using the rDNA sequence from T. brucei as query (NCBI locus tags TB927_01.rRNA.1 and onwards). The start of the rDNA arrays is marked with “Start of 18S rDNA” at the end of the alignment. For the multi-sequence alignment Clustal Omega was used (www.ebi.ac.uk/jdispatcher/msa/clustalo).
https://doi.org/10.1371/journal.pone.0322611.s001
(PDF)
S1 Fig. Verification of insertion in the chr13 rDNA spacer in Adea400 and Adea456 by Southern blot with BamHI.
The WT served as control. The blastR-targeting probe yielded single bands of the expected sizes for Adea400 (16252 bp) and Adea456 (18519 bp) but not for the WT (see S1 Table for expected sizes).
https://doi.org/10.1371/journal.pone.0322611.s002
(TIF)
S2 Fig. Epifluorescence microscopic analysis of Adea126 and Adea456 expressing mScarlet-ETP1.
DIC, differential interference contrast; H, blue channel (visualizing Hoechst 33342-stained DNA); mSc, red channel (visualizing mScarlet). Scale bar represents 10 µm.
https://doi.org/10.1371/journal.pone.0322611.s003
(TIF)
S1 Table. Expected Southern blot fragments for the verification of Adea400 and Adea456.
For the identification of the rDNA spacer, in which transgenes had been inserted, genomic DNA of the relevant strains was digested using a combination of BclI and SpeI or BamHI alone.
https://doi.org/10.1371/journal.pone.0322611.s004
(PDF)
S2 Table. Generation of recombinant plasmids by Golden Gate and Gibson cloning.
Vectors were generated by inserting specific inserts into already existing backbones. For the cloning, single to multi-fragment Gibson or Golden Gate assemblies were performed as indicated. Plasmids were either generated in the course of this work (“This paper”), described previously (Morales et al. 2023), or kindly provided by external parties. gDNA from a pLEXSY strain was obtained from Jena Bioscience.
https://doi.org/10.1371/journal.pone.0322611.s005
(XLSX)
S3 Table. Overview of A. deanei strains used in this study.
Enzymatically excised integration cassettes, containing expressed transgenes and stabilizing elements that are not translated, were integrated into the chromosomes of recipient strains. Correct insertion was verified by PCR and/or Southern blot. Strains were either generated in the course of this work (“This paper”) or described previously (Morales et al. 2023).
https://doi.org/10.1371/journal.pone.0322611.s006
(XLSX)
References
- 1. M. Motta MC. Endosymbiosis in trypanosomatids as a model to study cell evolution. Toparaj. 2010;4(1):139–47.
- 2. Harmer J, Yurchenko V, Nenarokova A, Lukeš J, Ginger ML. Farming, slaving and enslavement: histories of endosymbioses during kinetoplastid evolution. Parasitology. 2018;145(10):1311–23. pmid:29895336
- 3. Du Y, Maslov DA, Chang KP. Monophyletic origin of beta-division proteobacterial endosymbionts and their coevolution with insect trypanosomatid protozoa Blastocrithidia culicis and Crithidia spp. Proc Natl Acad Sci U S A. 1994;91(18):8437–41. pmid:7521530
- 4. Alves JMP, Serrano MG, Maia da Silva F, Voegtly LJ, Matveyev AV, Teixeira MMG, et al. Genome evolution and phylogenomic analysis of Candidatus Kinetoplastibacterium, the betaproteobacterial endosymbionts of Strigomonas and Angomonas. Genome Biol Evol. 2013;5(2):338–50. pmid:23345457
- 5. Motta MCM, Catta-Preta CMC, Schenkman S, de Azevedo Martins AC, Miranda K, de Souza W, et al. The bacterium endosymbiont of Crithidia deanei undergoes coordinated division with the host cell nucleus. PLoS One. 2010;5(8):e12415. pmid:20865129
- 6. Morales J, Kokkori S, Weidauer D, Chapman J, Goltsman E, Rokhsar D, et al. Development of a toolbox to dissect host-endosymbiont interactions and protein trafficking in the trypanosomatid Angomonas deanei. BMC Evol Biol. 2016;16(1):247. pmid:27835948
- 7. Morales J, Ehret G, Poschmann G, Reinicke T, Maurya AK, Kröninger L, et al. Host-symbiont interactions in Angomonas deanei include the evolution of a host-derived dynamin ring around the endosymbiont division site. Curr Biol. 2023;33(1):28-40.e7. pmid:36480982
- 8. Gonçalves CS, Catta-Preta CMC, Repolês B, Mottram JC, De Souza W, Machado CR, et al. Importance of Angomonas deanei KAP4 for kDNA arrangement, cell division and maintenance of the host-bacterium relationship. Sci Rep. 2021;11(1):9210. pmid:33911164
- 9. Catta-Preta CMC, Dos Santos Pascoalino B, de Souza W, Mottram JC, Motta MCM, Schenkman S. Reduction of tubulin expression in Angomonas deanei by RNAi modifies the ultrastructure of the trypanosomatid protozoan and impairs division of its endosymbiotic bacterium. J Eukaryot Microbiol. 2016;63(6):794–803. pmid:27194398
- 10. Maurya AK, Kröninger L, Ehret G, Bäumers M, Marson M, Scheu S, et al. A nucleus-encoded dynamin-like protein controls endosymbiont division in the trypanosomatid Angomonas deanei. Sci Adv. 2025;11(12):eadp8518. pmid:40106558
- 11. Clayton C. Regulation of gene expression in trypanosomatids: living with polycistronic transcription. Open Biol. 2019;9(6):190072. pmid:31164043
- 12. Maslov DA, Opperdoes FR, Kostygov AY, Hashimi H, Lukeš J, Yurchenko V. Recent advances in trypanosomatid research: genome organization, expression, metabolism, taxonomy and evolution. Parasitology. 2019;146(1):1–27. pmid:29898792
- 13. Martínez-Calvillo S, Vizuet-de-Rueda JC, Florencio-Martínez LE, Manning-Cela RG, Figueroa-Angulo EE. Gene expression in trypanosomatid parasites. J Biomed Biotechnol. 2010;2010:525241. pmid:20169133
- 14. Siegel TN, Hekstra DR, Kemp LE, Figueiredo LM, Lowell JE, Fenyo D, et al. Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei. Genes Dev. 2009;23(9):1063–76. pmid:19369410
- 15. Liang X, Haritan A, Uliel S, Michaeli S. trans and cis splicing in trypanosomatids: mechanism, factors, and regulation. Eukaryot Cell. 2003;2(5):830–40. pmid:14555465
- 16. Santos RERS, Silva GLA, Santos EV, Duncan SM, Mottram JC, Damasceno JD, et al. A DiCre recombinase-based system for inducible expression in Leishmania major. Mol Biochem Parasitol. 2017;216:45–8. pmid:28629935
- 17. Beneke T, Madden R, Makin L, Valli J, Sunter J, Gluenz E. A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids. R Soc Open Sci. 2017;4(5):170095. pmid:28573017
- 18. Burle-Caldas G de A, Grazielle-Silva V, Laibida LA, DaRocha WD, Teixeira SMR. Expanding the tool box for genetic manipulation of Trypanosoma cruzi. Mol Biochem Parasitol. 2015;203(1–2):25–33. pmid:26523948
- 19. Yagoubat A, Corrales RM, Bastien P, Lévêque MF, Sterkers Y. Gene editing in trypanosomatids: tips and tricks in the CRISPR-Cas9 era. Trends Parasitol. 2020;36(9):745–60. pmid:32703742
- 20. Kolev NG, Tschudi C, Ullu E. RNA interference in protozoan parasites: achievements and challenges. Eukaryot Cell. 2011;10(9):1156–63. pmid:21764910
- 21. Kushnir S, Gase K, Breitling R, Alexandrov K. Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae. Protein Expr Purif. 2005;42(1):37–46. pmid:15939291
- 22. Li F-J, Xu Z-S, Aye HM, Brasseur A, Lun Z-R, Tan KSW, et al. An efficient cumate-inducible system for procyclic and bloodstream form Trypanosoma brucei. Mol Biochem Parasitol. 2017;214:101–4. pmid:28438458
- 23. Wickstead B, Ersfeld K, Gull K. Targeting of a tetracycline-inducible expression system to the transcriptionally silent minichromosomes of Trypanosoma brucei. Mol Biochem Parasitol. 2002;125(1–2):211–6. pmid:12467990
- 24. Wirtz E, Leal S, Ochatt C, Cross GA. A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Mol Biochem Parasitol. 1999;99(1):89–101. pmid:10215027
- 25. White TC, Rudenko G, Borst P. Three small RNAs within the 10 kb trypanosome rRNA transcription unit are analogous to domain VII of other eukaryotic 28S rRNAs. Nucleic Acids Res. 1986;14(23):9471–89. pmid:3797245
- 26. Wirtz E, Clayton C. Inducible gene expression in trypanosomes mediated by a prokaryotic repressor. Science. 1995;268(5214):1179–83. pmid:7761835
- 27. Wirtz E, Hoek M, Cross GA. Regulated processive transcription of chromatin by T7 RNA polymerase in Trypanosoma brucei. Nucleic Acids Res. 1998;26(20):4626–34. pmid:9753730
- 28. Sunter J, Wickstead B, Gull K, Carrington M. A new generation of T7 RNA polymerase-independent inducible expression plasmids for Trypanosoma brucei. PLoS One. 2012;7(4):e35167. pmid:22511983
- 29. Espada CR, Quilles JC Jr, Albuquerque-Wendt A, Cruz MC, Beneke T, Lorenzon LB, et al. Effective genome editing in Leishmania (Viannia) braziliensis stably expressing Cas9 and T7 RNA polymerase. Front Cell Infect Microbiol. 2021;11:772311. pmid:34858879
- 30. Yao C, Luo J, Hsiao C-HC, Donelson JE, Wilson ME. Leishmania chagasi: a tetracycline-inducible cell line driven by T7 RNA polymerase. Exp Parasitol. 2007;116(3):205–13. pmid:17320870
- 31. Kraeva N, Ishemgulova A, Lukeš J, Yurchenko V. Tetracycline-inducible gene expression system in Leishmania mexicana. Mol Biochem Parasitol. 2014;198(1):11–3. pmid:25461484
- 32. Wang W, Li Y, Wang Y, Shi C, Li C, Li Q, et al. Bacteriophage T7 transcription system: an enabling tool in synthetic biology. Biotechnol Adv. 2018;36(8):2129–37. pmid:30290194
- 33. Studier FW, Moffatt BA. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986;189(1):113–30. pmid:3537305
- 34. Shanmugasundram A, Starns D, Böhme U, Amos B, Wilkinson PA, Harb OS, et al. TriTrypDB: An integrated functional genomics resource for kinetoplastida. PLoS Negl Trop Dis. 2023;17(1):e0011058. pmid:36656904
- 35. Moya A, Peretó J, Gil R, Latorre A. Learning how to live together: genomic insights into prokaryote-animal symbioses. Nat Rev Genet. 2008;9(3):218–29. pmid:18268509
- 36. Nowack ECM, Melkonian M. Endosymbiotic associations within protists. Philos Trans R Soc Lond B Biol Sci. 2010;365(1541):699–712. pmid:20124339
- 37. Husnik F, Tashyreva D, Boscaro V, George EE, Lukeš J, Keeling PJ. Bacterial and archaeal symbioses with protists. Curr Biol. 2021;31(13):R862–77. pmid:34256922
- 38. Goyard S, Beverley SM. Blasticidin resistance: a new independent marker for stable transfection of Leishmania. Mol Biochem Parasitol. 2000;108(2):249–52. pmid:10838227
- 39. Brooks DR, McCulloch R, Coombs GH, Mottram JC. Stable transformation of trypanosomatids through targeted chromosomal integration of the selectable marker gene encoding blasticidin S deaminase. FEMS Microbiol Letters. 2000;186(2):287–91.
- 40. Joshi PB, Webb JR, Davies JE, McMaster WR. The gene encoding streptothricin acetyltransferase (sat) as a selectable marker for Leishmania expression vectors. Gene. 1995;156(1):145–9. pmid:7737509
- 41. Marques CA, Ridgway M, Tinti M, Cassidy A, Horn D. Genome-scale RNA interference profiling of Trypanosoma brucei cell cycle progression defects. Nat Commun. 2022;13(1):5326. pmid:36088375
- 42. Knüsel S, Jenni A, Benninger M, Bütikofer P, Roditi I. Persistence of Trypanosoma brucei as early procyclic forms and social motility are dependent on glycosylphosphatidylinositol transamidase. Mol Microbiol. 2022;117(4):802–17. pmid:34954848
- 43. Rudenko G, Chung HM, Pham VP, Van der Ploeg LH. RNA polymerase I can mediate expression of CAT and neo protein-coding genes in Trypanosoma brucei. EMBO J. 1991;10(11):3387–97. pmid:1915299
- 44. Janz L, Clayton C. The PARP and rRNA promoters of Trypanosoma brucei are composed of dissimilar sequence elements that are functionally interchangeable. Mol Cell Biol. 1994;14(9):5804–11. pmid:8065315
- 45. Temme K, Hill R, Segall-Shapiro TH, Moser F, Voigt CA. Modular control of multiple pathways using engineered orthogonal T7 polymerases. Nucleic Acids Res. 2012;40(17):8773–81. pmid:22743271
- 46. Wirtz E, Hartmann C, Clayton C. Gene expression mediated by bacteriophage T3 and T7 RNA polymerases in transgenic trypanosomes. Nucleic Acids Res. 1994;22(19):3887–94. pmid:7937108
- 47. Kamionka A, Bogdanska-Urbaniak J, Scholz O, Hillen W. Two mutations in the tetracycline repressor change the inducer anhydrotetracycline to a corepressor. Nucleic Acids Res. 2004;32(2):842–7. pmid:14764926
- 48. Resch M, Striegl H, Henssler EM, Sevvana M, Egerer-Sieber C, Schiltz E, et al. A protein functional leap: how a single mutation reverses the function of the transcription regulator TetR. Nucleic Acids Res. 2008;36(13):4390–401. pmid:18587152
- 49. Mullick A, Xu Y, Warren R, Koutroumanis M, Guilbault C, Broussau S, et al. The cumate gene-switch: a system for regulated expression in mammalian cells. BMC Biotechnol. 2006;6:43. pmid:17083727
- 50. Lieber A, Sandig V, Strauss M. A mutant T7 phage promoter is specifically transcribed by T7-RNA polymerase in mammalian cells. Eur J Biochem. 1993;217(1):387–94. pmid:8223577
- 51. Komura R, Aoki W, Motone K, Satomura A, Ueda M. High-throughput evaluation of T7 promoter variants using biased randomization and DNA barcoding. PLoS One. 2018;13(5):e0196905. pmid:29734387
- 52. Conrad T, Plumbom I, Alcobendas M, Vidal R, Sauer S. Maximizing transcription of nucleic acids with efficient T7 promoters. Commun Biol. 2020;3(1):439. pmid:32796901
- 53. Kushnir S, Cirstea IC, Basiliya L, Lupilova N, Breitling R, Alexandrov K. Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae. Mol Biochem Parasitol. 2011;176(2):69–79. pmid:21167214
- 54. Gibson DG, Young L, Chuang R-Y, Venter JC, Hutchison CA 3rd, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6(5):343–5. pmid:19363495
- 55. Engler C, Kandzia R, Marillonnet S. A one pot, one step, precision cloning method with high throughput capability. PLoS One. 2008;3(11):e3647. pmid:18985154
- 56. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. pmid:22743772
- 57. Sanial M, Miled R, Alves M, Claret S, Joly N, Proux-Gillardeaux V, et al. Direct observation of fluorescent proteins in gels: a rapid cost-efficient, and quantitative alternative to immunoblotting. bioRxiv. 2024;33: 594679. Available: https://www.biorxiv.org/content/10.1101/2024.05.31.594679v1